Peripheral inflammatory molecules, such as IL-1β, IL-2, IL-6, IL-10, TNF-α, and high-sensitivity C-reactive protein (hs-CRP), could be used as potential biomarkers to reflect the neuroinflammatory pathogenesis of PD. This evidence concerns the gene IL2 and Parkinson disease.